The baseline survey of the Longitudinal Study of Ageing and Health in Viet Nam (LSAHV) had the participation of 6,050 older persons aged 60 and above. The study shows an overall picture of the older persons in Viet Nam, including demographic characteristics, health status, various aspects of health and well-being with respect to age and sex of older persons as well as the economic status and social relationships of the older persons.
IV Congresso Internacional CBA2017
17 a 19 de setembro de 2017
Medicina Digital e as Novas Fronteiras: da Assistência à Pesquisa
Roberto Botelho MD, PhD
Connectacare
The baseline survey of the Longitudinal Study of Ageing and Health in Viet Nam (LSAHV) had the participation of 6,050 older persons aged 60 and above. The study shows an overall picture of the older persons in Viet Nam, including demographic characteristics, health status, various aspects of health and well-being with respect to age and sex of older persons as well as the economic status and social relationships of the older persons.
IV Congresso Internacional CBA2017
17 a 19 de setembro de 2017
Medicina Digital e as Novas Fronteiras: da Assistência à Pesquisa
Roberto Botelho MD, PhD
Connectacare
A selection of key indicators from "Health at a Glance 2019: OECD Indicators", released on November 7, 2019. More info at http://www.oecd.org/health/health-at-a-glance.htm.
Australia's health system needs to better connect the dots in a number of areas. Our work looks at connections between Australian chronic disease targets and indicators, WHO targets and indicators, and national progress.
Mental Diseases are more common than cancer, diabetes or heart diseases. However it's often under recognized and stigmatized. Hopefully in 2015 some entrepreneurs are trying to tackle this field in an innovative way.
Catastrophic health expenditure and poverty and Malawi by Martina Rhino MchengaIFPRIMaSSP
Out-of-pocket (OOP) health payments can cause financial hardship to households, which may push them into poverty. The paper investigated the impact of OOP health payments on households’ economic situation in Malawi using data from the Third Integrated Household Survey (IHS3). The study adopts the World Health Organization’s approach in measuring the extent of catastrophic health expenditure and impoverishment. Within the framework of OOP health payments on household’s economic status, the paper computes new poverty estimates. These poverty estimates purportedly take into account the poverty impact of OOP health payments. It is found that if OOP health payments are factored in, the level of poverty in Malawi is higher than official figures suggest. For instance, an additional of 0.93% of households fall below the poverty line after paying for health care. It also uses a logit model to identify the determinants of catastrophic health expenditures. It is found that chronically sick members, large number of illness episodes and large households are highly likely to incur catastrophic health expenditure.
What are scalable best practices to spread smart health? SharpBrains
Maximizing health and well-being requires quality decision-making and positive lifestyles across millions, if not billions, of individual decision-makers. How can we accelerate the adoption of smart health behaviors in scalable and systematic ways, ensuring benefits at both the individual and population levels, and empowering consumers, patients and professionals?
- Chair: Jayne Plunkett, Head of Casualty Reinsurance at Swiss Re, YGL Class of 2010
- Misha Pavel, Program Director of Smart and Connected Health at the National Science Foundation
- Dharma Singh Khalsa, President of the Alzheimer’s Research and Prevention Foundation
- Josh Wright, Managing Director of ideas42
This session took place at the 2013 SharpBrains Virtual Summit: http://sharpbrains.com/summit-2013/agenda/
Dr John Wren
Principal Researcher Advisor
New Zealand Accident Compensation Corporation
PO Box 242, Wellington, New Zealand
john.wren@acc.co.nz
(P23, Thursday 27, Civic Room 3, 1.30)
SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...Sherbrooke Innopole
By: Pierre-Carl Michaud, Industrial Alliance Research Chair on the Economics of Demographic Change
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
The baseline survey of the Longitudinal Study of Ageing and Health in Viet Nam (LSAHV) has the participation of 6,050 older persons aged 60 and above. The study shows an overall picture of the older persons in Viet Nam, including demographic characteristics, health status, various aspects of health and well-being with respect to age and sex of older persons as well as the economic status and social relationships of the older persons.
A selection of key indicators from "Health at a Glance 2019: OECD Indicators", released on November 7, 2019. More info at http://www.oecd.org/health/health-at-a-glance.htm.
Australia's health system needs to better connect the dots in a number of areas. Our work looks at connections between Australian chronic disease targets and indicators, WHO targets and indicators, and national progress.
Mental Diseases are more common than cancer, diabetes or heart diseases. However it's often under recognized and stigmatized. Hopefully in 2015 some entrepreneurs are trying to tackle this field in an innovative way.
Catastrophic health expenditure and poverty and Malawi by Martina Rhino MchengaIFPRIMaSSP
Out-of-pocket (OOP) health payments can cause financial hardship to households, which may push them into poverty. The paper investigated the impact of OOP health payments on households’ economic situation in Malawi using data from the Third Integrated Household Survey (IHS3). The study adopts the World Health Organization’s approach in measuring the extent of catastrophic health expenditure and impoverishment. Within the framework of OOP health payments on household’s economic status, the paper computes new poverty estimates. These poverty estimates purportedly take into account the poverty impact of OOP health payments. It is found that if OOP health payments are factored in, the level of poverty in Malawi is higher than official figures suggest. For instance, an additional of 0.93% of households fall below the poverty line after paying for health care. It also uses a logit model to identify the determinants of catastrophic health expenditures. It is found that chronically sick members, large number of illness episodes and large households are highly likely to incur catastrophic health expenditure.
What are scalable best practices to spread smart health? SharpBrains
Maximizing health and well-being requires quality decision-making and positive lifestyles across millions, if not billions, of individual decision-makers. How can we accelerate the adoption of smart health behaviors in scalable and systematic ways, ensuring benefits at both the individual and population levels, and empowering consumers, patients and professionals?
- Chair: Jayne Plunkett, Head of Casualty Reinsurance at Swiss Re, YGL Class of 2010
- Misha Pavel, Program Director of Smart and Connected Health at the National Science Foundation
- Dharma Singh Khalsa, President of the Alzheimer’s Research and Prevention Foundation
- Josh Wright, Managing Director of ideas42
This session took place at the 2013 SharpBrains Virtual Summit: http://sharpbrains.com/summit-2013/agenda/
Dr John Wren
Principal Researcher Advisor
New Zealand Accident Compensation Corporation
PO Box 242, Wellington, New Zealand
john.wren@acc.co.nz
(P23, Thursday 27, Civic Room 3, 1.30)
SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...Sherbrooke Innopole
By: Pierre-Carl Michaud, Industrial Alliance Research Chair on the Economics of Demographic Change
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
The baseline survey of the Longitudinal Study of Ageing and Health in Viet Nam (LSAHV) has the participation of 6,050 older persons aged 60 and above. The study shows an overall picture of the older persons in Viet Nam, including demographic characteristics, health status, various aspects of health and well-being with respect to age and sex of older persons as well as the economic status and social relationships of the older persons.
Japan’s health care system is a source of great pride for the country. Japan attained universal health coverage over 50 years ago and the country's health outcomes are some of the best in the world by many measures, while health care spending is at relatively low levels.
Despite the many positive aspects of the system, it faces challenges. The demographic wave of rising numbers of elderly will put new pressures on the care delivery system and the nation’s budget. Moreover, the country has high utilization of many health care services, care delivery is often fragmented, and measures of quality are not commonly available or necessarily used for continuous improvement. How will Japan address these issues and manage the health care needs and rising costs of its aged and still aging society? What can other countries, such as the United States, learn from the Japanese experience, and can new care delivery innovations taking place around the globe help address Japan's challenges?
G7 high-level side event in Niigata: Healthy ageing and prevention
Date: Wednesday 10 May 2023
Time: 2.00pm – 3.30pm (JST), followed by networking with refreshments
Location: Niigata, Japan
Presented at the 66th session of the WHO Regional Committee for Europe by:
Dr Oleg Chestnov, Assistant Director-General, WHO
Dr Jill Farrington, Acting Head, NCD Project Office, Moscow
Dr Gauden Galea, Director, Noncommunicable Diseases and
Promoting Health through the Life-course, WHO/Europe
“IFPRI Egypt Webinars” is a special edition of the IFPRI Egypt Seminar Series funded by USAID. This webinar took place under the title of “COVID-19 and social protection: from effective crisis protection to self-reliance”
Presentation by our Keynote Speaker, Leslie J. Kohman, MD at our Cancer Mission 2020 28th Congressional District Summit in Buffalo, NY. Dr. Kohman is the Professor of Surgery Medical Director at Upstate Cancer Center in Syracuse, NY.
Tom Kirkwood - High impact health interventionsAge UK
Professor Tom Kirkwood, Associate Dean for Ageing, University of Newcastle - presentation from Age UK's For Later Life conference, 25th April.
For more information: www.ageuk.org.uk/forlaterlife
Similar to Presenting the ACCJ-EBC Health Policy White Paper 2013 (20)
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
3. About American Chamber of Commerce in
Japan
Established
1948
Committee structure drives Chamber
activities around three pillars:
• Information
• Networking
• Advocacy
Approximately
2700 members
representing
1000 companies
Over 500 events
per year in three
chapters across
Japan
Approximately
half of members
are Japanese
4. Achieving Growth Together
Japan Economic
Growth
ACCJ Membership
Growth
ACCJ Member
Personal Growth
ACCJ’s Three Primary Areas for Growth
成共
長就
5. Preventive Health Investment Drives Growth
Japan’s aging is rapidly increasing healthcare utilization
Worker productivity is key to sustain healthcare and grow
the economy
• Disease costs Japanese economy 3.3 trillion yen per year in lost
productivity (2011 ACCJ National Survey)
A shift to prevention and early detection is necessary to:
Increase healthy life years
Lower economic burden of disease
Support economic growth
6. • Gaps between average life expectancy and healthy life expectancy
represent an unhealthy period with daily life constraints
• There may be medical andnursingexpenses during this period
70.42
79.64
60
73.62
86.39
65 70 75 80 85 90
Year
9.22years
12.77years
Average life expectancy Healthylifeexpectancy(Nodailylifeconstraints)
Gapbetweenaverageandhealthylifeexpectancy
Male
Female
Source: Healthy Japan 21 (Second Version)
Importance of Healthier Life Expectancy
7. ACCJ-EBC Health Policy White Paper 2013
Promoting economic growth in Japan
through policies to lengthen healthy
lifespans and
reduce economic burden of preventable,
detectable and treatable diseases
36 healthcare topics
Over 150 policy
recommendations
9. About European Business Council in Japan
Trade policy arm
of 17 European
National
Chambers of
Commerce and
Business
Associations in
Japan
Working to improve the trade and
investment environment for European
companies in Japan since
1972
Approximately 3000 local European
corporate and individual members
Approximately
400 companies
participating
directly
10. Rise in Non-Communicable Diseases Is a
Leading Threat to Global Economic Growth
WHO report: each 10% rise in non-
communicable diseases is linked to a
0.5% dip in annual economic growth;
recent global rise in NCDs is
“economically unsustainable.”
The World Economic Forum forecasts
that NCDs will cost the global economy
$47 trillion over the next 20 years.
• Stuckler D. “Population causes & consequences of leading chronic diseases: a comparative analysis of prevailing explanations.”
Milbank Quarterly, 2008, 86:273–326. Reported in Global Status Report on Noncommunicable Diseases 2010,” WHO,
http://www.who.int/nmh/publications/ncd_report2010/en/
• Working Towards Wellness: The Business Rationale. World Economic Forum, Geneva, 2008. Bloom, et al., 2011.
11. NCDs account for about 30% of national healthcareexpenditure and
about 60% of total deaths
HealthcareExpenditure
Cancers11.1%
Hypertension-
relateddiseases7.1
%
Cerebralvasculardis
eases6.3%
Diabetes4.4%
Cardiovascular
diseases2.9%
Others
68.3%
Cancers
29.5%
Cardiovasculardi
seases15.8%
Cerebral vascular
diseases 10.3%
Diabetes1.2%
Hypertension-
relateddiseases0.6%
Others
42.6%
Mortality
Source: Healthy Japan 21 (Part 2)
Non-Communicable Diseases in Japan are
Costly, Deadly and Often Preventable
12. “Every 1 year increase in life
expectancy is linked to a 4.3%
increase in global GDP.”
Sources: Stuckler D. “Population causes & consequences of leading chronic diseases: a comparative analysis of prevailing explanations.”
Milbank Quarterly, 2008, 86:273–326. Reported in Global Status Report on Noncommunicable Diseases 2010, WHO,
http://www.who.int/nmh/publications/ncd_report2010/en/.
Spending to Promote Health is a Very Good
Economic Investment
15. 2011 Health Policy White Paper
2011
Scope:
• 27 Topic Sections
• 124 Recommendations
Results:
• 46 of 124 recommendations (roughly 37%)
fulfilled “in part" or in whole
Areas of Progress:
• Continued government funding of national
cancer screening
• Substantial increased funding to enhance
infection prevention and control at hospitals
in Japan (four fold for hospitals with >300
beds).
• Expanded use of IVD Rapid Diagnostics
• Diabetes Management
• Osteoporosis Prevention
• Chronic Pain Research Funding
• Vaccination Policy
• Hepatitis Screening & Awareness Initiatives
16. Source: Inhibitex
Nearly 6 million HAIs
annually in U.S., Europe and
Japan
1.7 million cases and 99,000
deaths annually in the U.S.
In some developing countries,
more than 25% of patients
admitted to hospitals acquire
HAIs
Hundreds of millions of
patients impacted worldwide
each year
Healthcare Associated Infections (HAIs):
A Global Healthcare Issue
Millions of Infections
8
6
4
2
0
2002 2005 2009 2010 2015
5.6 5.9
6.3 6.4
6.9
Japan
Europe
U.S.
17. Q. How important do you think it is for the government to have a national
program to reduce the risk of infections associated with hospitals, clinics
or other healthcare facilities?
75.7% of General Public in Japan Think it is
Important to Have a National Program to Reduce
the Risk of HAIs (80% for population over 65)
■Important ■Slightly important■Neither nor ■Do not know ■Not very important ■Not important
52.4
48.9
48.5
43.0
37.3
31.4
29.4
40.8
40.2
40.5
27.4
30.6
32.9
36.2
36.4
39.2
38.1
35.9
34.4
35.2
7.7
12.9
11.2
12.1
15.9
17.6
18.6
14.4
14.2
14.3
10.6
5.6
5.6
5.9
7.4
7.9
7.4
6.3
7.2
6.8
1.9
1.4
1.2
2.1
1.8
2.5
6.6
2.0
2.2
2.1
0% 20% 40% 60% 80% 100%
80+ yrs old (n=208)
70-79 yrs old (n=790)
60-69 yrs old (n=882)
50-59 yrs old (n=779)
40-49 yrs old (n=800)
30-39 yrs old (n=863)
20-29 yrs old (n=678)
Female (n=2599)
Male (n=2401)
Overall (n=5000)
Is Important
75.7%
74.6%
76.6%
67.4%
70.6%
73.6%
79.2%
81.4%
79.5%
79.8%
Not Important
3.3%
3.9%
2.6%
6.6%
3.9%
3.2%
2.9%
1.8%
2.0%
1.9%
Survey on Prevention, Early Detection and the Economic Burden of Disease in Japan (2011) by The American Chamber of Commerce in
Japan. Internet survey conducted October 31 – November 2, 2011. 5,000 respondents from Rakuten Research’s registry that represent
the Japanese population.
18. 2013
2013 ACCJ-EBC Health Policy White Paper
Scope:
• 36 Topic Sections
• 156 Recommendations
Chapters:
1. General Health Themes
2. Non-communicable Disease
(NCD) Topics
3. Women’s Health Topics
4. Key Infectious Disease Topics
5. Importance of Enhanced Safety
& Infection Control
6. Special Focus Needed on
Healthcare Worker Safety
20. Deaths Caused by and Patients of
Cerebrovascular Diseases
100
125
150
175
200
0
250
500
750
1,000
1,250
1,500
1,750
2,000
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
# of death
(1,000 ppl)
# of Patients
(1,000 ppl)
# of
Patients
# of
Death
Source: Ministry of Health, Labor, and Welfare (Trend of Medical Institution)
25. 71.5% of Japanese Back Introduction of Electronic
Health Records at Hospitals, Clinics
Support/Agree Slightly Support/Agree Neither
Don’t know SlightlyOppose/Disagree Oppose/Disagree
50.0
48.2
52.4
42.2
40.3
35.9
36.1
37.9
48.7
43.1
23.6
28.0
24.3
28.4
28.3
33.4
29.8
31.6
25.0
28.4
14.4
16.1
17.1
22.2
22.8
20.4
20.8
21.8
17.2
19.6
10.1
5.1
4.4
5.4
5.9
6.6
8.3
5.9
6.2
6.0
0.5
1.9
1.5
1.2
2.3
2.5
2.9
2.2
1.7
2.0
0% 20% 40% 60% 80% 100%
80+ yrs old (n=208)
70-79 yrs old (n=790)
60-69 yrs old (n=882)
50-59 yrs old (n=779)
40-49 yrs old (n=800)
30-39 yrs old (n=863)
20-29 yrs old (n=678)
Female (n=2599)
Male (n=2401)
Overall (n=5000) 71.5%
73.7%
69.4%
65.9%
69.3%
68.5%
70.6%
76.6%
76.2%
73.6%
Support Oppose
2.9%
2.9%
2.9%
5.0%
3.7%
2.9%
1.8%
1.8%
2.7%
1.9%
Q: Do you support or oppose the introduction of electronic health records at
hospitals and clinics in Japan?
Source: ACCJ National Survey on Prevention, Early Detection & the Burden of Disease in Japan, Nov, 2011.
26. Supporters of EHR System Expect
More Efficiency, Safer Medical Service
(n=3,574)
Q: Why do you support the introduction of an electronic health record (EHR) system
at hospitals and clinics in Japan? (multiple answers)
Source: ACCJ National Survey on Prevention, Early Detection & the Burden of Disease in Japan, Nov. 2011.
27. 24.3%
70% 75%
Breast Cancer Screening Rates Lower Than
OECD Average
Sources:
http://www.mhlw.go.jp/stf/houdou/2r9852000001igt0.html, http://www.oecdto
Mammography
screening rates
in Japan rising,
but still low
62.2%
Free National Breast Cancer Screening
Launched in 2009
Scope: Women aged 40, 45, 50, 55, and 60
Funding: 100% by central government
Japan Goal: 50% screening rate by 2011
Recruitment: Send coupons to eligible women
28. Has a 28% survival
rate over five years
Costs up to ¥4
million to treat
Has 96% survival
rate over five
years
Costs about
¥760,000 to treat
Breast cancer diagnosed
in early stages
Breast cancer diagnosed
after it has metastasized
Breast Cancer Screening:
Cost Effective and Saves Lives
Sense no need, as have no
lump
Lack of opportunity
High fees
Top three reasons
women do not have
a mammogram
30. Two Thirds Support a Mandated Indoor
Worksite Smoking Ban
Question: What would you think if the national or local governments legally required
a complete smoking ban in all indoor workplaces and public spaces, including
restaurants, bars and taxis, to protect the health of non-smoking workers?
Source: Japan national survey on passive smoking in the workplace for 8,000 indoor workers by Johnson &
Johnson K.K. Consumer Company, released on July 19th, 2012
31. 70% of Indoor Workers: Legal Smoking Ban
Would Not Negatively Impact Business
Question: How would your business be impacted if national or local governments
legally required a total smoking ban in all indoor workplaces and public
spaces, including restaurants, bars and taxis, to protect the health of non-smoking
workers?
Source: Japan national survey on passive smoking in the workplace of 8,000 indoor workers by Johnson & Johnson K.K. Consumer Company, July 2012
32. 322011 MHLW’ National Survey on Getting-tested status of Hepatitis Screening (Interviewed 74,000 Japanese people aged 20 thru 79 years old)
Only Half of Adults in Japan Have Been
Screened for Hepatitis
Japanese government has provided free hepatitis screening since 2002 as the
time of regular health checkup services by municipal governments. Free
screening was first provided at public health centers and later also available at
hospitals and clinics.
Need to further increase screening rate, especially for people aged 40 and over.
HCV Screening Rate: Est. 48%HCB Screening Rate: Est. 57%
Tested at time
of
surgery, pregn
ancy, blood
donation 40%
No, I have
not or do
not know
42%
Yes, I have
been tested
(self-
reported)
18%
Yes, I have
been tested
(self-
reported)
18%
No, I have
not or do
not know
52%
Tested at time
of
surgery, pregn
ancy, blood
donation 30%
33. Large Company
Employers
Small and Medium
Company Employers
Self-Employed and
Others
Type of health
insurance in which
employee enrolls
Managed by health
insurance societies or
associations
Managed by members
of Japan Health
Insurance Association
Managed by
municipalities, National
Health Insurance
associations
Provision of health
checkups based on
Industrial Safety &
Health Act
Yes, required
(Employers are required to provide)
Not required
Provision of special
health checkups based
on Law for the Welfare
of the Elderly (aged 40
or over)
Yes, provision is required
(Insurance provider is required to provide)
Rate at which hepatitis
screening is part of
special health checkup
Approx. 50% Approx. 95%
Individuals must pay ¥595
as co-payment and apply
separately for this optional
hepatitis virus testing.
Approx. 80%
Free but implementation
varies by town, city.
Screening notices usually
go to specific age groups.
Source: MHLW, “Status of implementation of Specific Medical Checkups/Health Guidance in FY2010”
http://www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/info03_h22.html
Provision of Hepatitis Screening Varies
Widely According to Type of Insurer
34. 2013 ACCJ-EBC Health Policy White Paper
• Paradigm shift from treatment to prevention
Focusing on prevention, screening, early detection and early treatment of
disease
• Efficient allocation of healthcare resources
Enhancing productivity and reducing waste
• Evidence-based global best practices
Recommendations with potential to yield significant positive impact
• Alignment with government growth policy goals
Recommendations with potential to boost economic growth
Disease prevention • Cost effective interventions
• Better patient outcomes and quality of life •
Enhanced labor productivity
35. Presenting the ACCJ-EBC
Health Policy White Paper 2013
May 31, 2013
Lengthening Healthy Lifespans
to Boost Economic Growth
Editor's Notes
Established in 1948Approximately 2700 members representing 1000 companiesOver 500 events per year in three chapters across Japan:Tokyo, Chubu (Nagoya), Kansai (Osaka)Approximately half of the members are JapaneseCommittee structure drives Chamber activities around three pillarsInformationNetworkingAdvocacy
In 2013, ACCJ is addressing three primary areas for growth:Japan’s economic growthACCJ membership growthACCJ member personal growth
Japan is an aging society with a declining population.High productivity level of the labor force is a primary source of Japan’s international competitiveness and economic growth.ACCJ’s 2011 national survey shows that disease costs Japanese economy 3.3 trillion yen per year in lost productivity, and higher level of absenteeism and disability. This figure does not include economic loss due to medical expenditure.Investment in health now focuses on lowering the economic burden and supporting economic growth, by reducing the burden of preventable, detectable and treatable disease through prevention, screening, early detection and the early treatment of disease.Such investment will improve patient outcomes, improve quality of life, increase worker productivity and ultimately support economic growth.
There is a significantgap between Japan’s average life expectancy and its healthy life expectancy.People are living longer but many of those life years are spent ill or in need of treatment or care.It is critical to raise the healthy life expectancy to the level of average life expectancy, because:It enhances people’s livesIt increases labor productivity It shifts healthcare expenditure from treatment to prevention, which is an investment in growth
ACCJ and EBC are pleased to offer this white paper in an effort to support economic growth in Japan through policies that lengthen healthy lifespans and reduce the economic burden of preventable, detectable and treatable diseases.Recommendations are aimed at putting a greater emphasis on prevention and early detection and are based on global evidence and best practices.The ACCJ and EBC agreed to work together to issue our first joint Health Policy White Paper, to enhance the scope and quality of our recommendations and to align our recommendations with current government growth policy goalsWe believe the 2013 ACCJ-EBC Health Policy White Paper represents our most comprehensive set of healthcare policy recommendations to date.Now I will turn to Duco Delgorge, our valued partner in this very exciting endeavor.
The European Business Council in Japan (EBC) is the trade policy arm of 17 European National Chambers of Commerce and Business Associations in Japan and has been working to improve the trade and investment environment for European companies in Japan since 1972. The EBC currently works for around 3,000 local European corporate and individual members with some 400 companies participating directly in the EBC’s 30 sector-based committees.The common bond among the members of the EBC and ACCJ is the desire to improve the quality of healthcare in Japan and the wellbeing of the Japanese people.
Globally and in Japan, more people are living longer.However, many of those years are increasingly spent under care for chronic – often preventable --disease.A shift from a purely disease treatment paradigm to a prevention paradigm that focuses on prevention, screening, early detection and the early treatment of disease holds the promise of not only preventing disease and enhancing quality of life and worker productivity, but in yielding cost effective interventions and better patient outcomes.
Many forms of chronic disease can be prevented or detected early, but health policies in Japan have traditionally focused on the treatment of disease after it occurs or grows critical, which can result in higher treatment costs.Here, you can see the significant proportion of healthcare expenditure and deaths that are due to non-communicable diseasesThese are conditions that, if prevented or detected earlier, would pose a much lighter burden on Japanese healthcare system, which is surely a benefit to society.
Finally, not only does preventative health and early detection of disease improve patient outcomes and create efficiencies in the healthcare system, it is an investment in the overall economic output and competitiveness of Japan.A more efficient allocation of healthcare resources that provides better patient outcomes boosts the economy in two important ways: it enhances labor productivity and reduces waste. Our goal is to provide recommendations founded on evidence-based global best practices and to offer these as examples of the kinds of policies likely to yield significant positive potential impact.
Background Since 2008, the ACCJ Healthcare Committee has released a series of Viewpoints advocating a shift from a purely disease treatment paradigm to a prevention paradigm that focuses on prevention, screening, early detection and the early treatment of disease which holds the promised of not only preventing disease and enhancing quality of life and worker productivity, but in yielding cost effective interventions and better patient outcomes.
Slide #1In 2010, the first Health Policy White Paper was issued as a companion document covering healthcare reform recommendations for the ACCJ white paper “Charting a new Course for Growth – Recommendations for Japan’s Leaders” issued by the ACCJ Growth Strategy Taskforce, which highlighted the initiatives that will enable Japan to achieve the goal of enhancing economic growth.
Slide#2In 2011, the ACCJ Health Policy White Paper was greatly expanded from 12 topic sections to 27 topic sections under the title “Investing in Health as a Competitive Advantage- Proposals to Reduce the Burden of Disease by Promoting Prevention and Early Detection”. Again, the goal was to support Japan’s economic growth strategy. It has been our goal to provide recommendations founded on evidence-based global best practices and to offer these as examples of the kinds of policies likely to yield significant positive potential impact. That being said, to gage the effectiveness of the 2011 white paper recommendations, a review was conducted after the implementation of reforms on April 1, 2012. In brief, forty-six (or roughly 37%) of the one hundred twenty-four (124) recommendations in the 2011 Health Policy White Paper were found to have been fulfilled "In Part" or in whole. Notable progress was made in: Expansion of IVD Rapid Diagnostics; Diabetes Management; Osteoporosis Prevention; Chronic Pain Research Funding; Vaccination Policy and Hepatitis Screening and Awareness Initiatives. The most significant progress was seen in the continued government funding of national cancer screening initiatives and in the substantial increase in government funding to enhance infection prevention and control at hospitals in Japan (four fold for hospitals with >300 beds).
Slide #5To update and further enhance the quality of the Health Policy White Paper and to align our recommendations with current government growth policy goals, the ACCJ and EBC agreed to work together to issue our first joint health policy white paper, “ACCJ–EBC Health Policy White Paper 2013 - Lengthening Healthy Lifespans to Boost Economic Growth”. Several new or expanded topic sections were added to the 2013 white paper including new topics sections for mental health, noncommunicable diseases, infection prevention & control and healthcare worker safety. The 2013 white paper is divided into Six Chapters, covering 36 topic sections and over 150 policy recommendations.General Health Themes Noncommunicable Disease (NCD) TopicsWomen’s Health TopicsKey Infectious Disease TopicsImportance of Enhanced Safety & Infection ControlSpecial Focus Needed on Healthcare Worker Safety Again, our goal is to provide recommendations founded on evidence-based global best practices and to offer these as examples of the kinds of policies likely to yield significant positive potential impact. Thanks to our collaboration with our European colleagues, we believe the 2013 ACCJ-EBC Health Policy White Paper represents our most comprehensive set of healthcare policy recommendations to date.